REGENXBIO Inc is a well-known figure in the global biotech sphere committed to the discovery, development and commercialisation of innovative therapies. Operating on an international scale, the company uses next-generation technologies for addressing severe medical conditions.
Positioned within the biotechnology and healthcare sectors, REGENXBIO harnesses proprietary NAV technology to develop therapies for genetic and rare diseases along with retinal, neuromuscular diseases and neurodegenerative disorders. Although it stands as an independent entity, the firm has collaborations in place with leading pharmaceutical companies to expand its therapeutic touch.
Monitor the RGNX share price on your eToro watchlist.